Amesite reports 69% QoQ revenue growth in Q2 2026, plans AI-powered EMR launch

Amesite Inc.

2026-Q1 EPS reported -$0.14 revenue$94,296

Q2 2026 revenue rose 69% QoQ; operating expenses cut.
Cash ~$2M, zero debt, 4.6M shares outstanding as of Sep 30, 2025.
Plans to launch industry-first AI-powered EMR for post-acute care by Q2 2026.
Customer engagement: 6,500 daily video views, 28,000 daily website visitors.
Avg B2B pipeline deal ~600 users; targeting profitability with <10K users.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.